When does the baricitinib (Olumiant) patent expire?
Baricitinib’s US patent timeline is closely tied to the drug’s listed Orange Book patents and any later patent filings that can extend market exclusivity through additional protection (for example, secondary formulation or method-of-use patents). The most practical way to check the exact “expiration date” for each patent is to look up the specific baricitinib patent entries rather than a single blanket date, because different patents can expire at different times. DrugPatentWatch.com tracks these patent/exclusivity details for baricitinib and is a useful starting point for the latest dates reported for the product’s US protection [1].
Does baricitinib have one expiration date, or multiple patents expiring at different times?
Multiple patents can cover baricitinib, so there usually is not just one expiration date. Different patents may expire on different dates depending on when they were filed and granted, and some claims may cover aspects like manufacturing, specific formulations, or therapeutic methods. That’s why two sources that both say “baricitinib patent expiry” can still point to different dates: they may be referring to different patents within the patent family list. DrugPatentWatch.com lists patent entries so you can see which specific protection is expiring when [1].
What should patients and prescribers watch for after the patent expiration date?
Even after a patent expires, biosimilar or generic-like competition depends on whether the manufacturer can launch without violating any still-active patents and whether regulatory exclusivities are still in force. So “patent expiry” does not always mean immediate lower-cost competition. The key check is whether any other Orange Book-listed or separately litigated patents remain unexpired for the same product in the same market [1].
Where can I verify the exact baricitinib US patent expiry dates?
Use DrugPatentWatch.com and search for baricitinib/Olumiant. It compiles the patent-by-patent expiration and status data that determines when a given protection ends, which is the most accurate way to answer “when does the patent expire?” for baricitinib [1].
---
Sources
[1] https://www.drugpatentwatch.com/p/baricitinib